EP1005340A4 - Retinoid antagonists for prevention of surgical adhesions - Google Patents

Retinoid antagonists for prevention of surgical adhesions

Info

Publication number
EP1005340A4
EP1005340A4 EP98918060A EP98918060A EP1005340A4 EP 1005340 A4 EP1005340 A4 EP 1005340A4 EP 98918060 A EP98918060 A EP 98918060A EP 98918060 A EP98918060 A EP 98918060A EP 1005340 A4 EP1005340 A4 EP 1005340A4
Authority
EP
European Patent Office
Prior art keywords
prevention
surgical adhesions
retinoid antagonists
retinoid
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98918060A
Other languages
German (de)
French (fr)
Other versions
EP1005340A1 (en
Inventor
Kenneth M Tramposch
Xina Nair
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of EP1005340A1 publication Critical patent/EP1005340A1/en
Publication of EP1005340A4 publication Critical patent/EP1005340A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EP98918060A 1997-04-11 1998-04-09 Retinoid antagonists for prevention of surgical adhesions Withdrawn EP1005340A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4352897P 1997-04-11 1997-04-11
US43528P 1997-04-11
US5075197P 1997-06-25 1997-06-25
US50751P 1997-06-25
PCT/US1998/007060 WO1998046223A1 (en) 1997-04-11 1998-04-09 Retinoid antagonists for prevention of surgical adhesions

Publications (2)

Publication Number Publication Date
EP1005340A1 EP1005340A1 (en) 2000-06-07
EP1005340A4 true EP1005340A4 (en) 2001-02-07

Family

ID=26720518

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98918060A Withdrawn EP1005340A4 (en) 1997-04-11 1998-04-09 Retinoid antagonists for prevention of surgical adhesions

Country Status (5)

Country Link
EP (1) EP1005340A4 (en)
JP (1) JP2001524082A (en)
AU (1) AU723146B2 (en)
CA (1) CA2286261A1 (en)
WO (1) WO1998046223A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022113A2 (en) 2000-09-13 2002-03-21 Bristol-Myers Squibb Company Retinoic acid receptor antagonists as promoters of angiogenesis
AU2003302070A1 (en) * 2002-11-15 2004-06-15 Galderma Research And Development, S.N.C. USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta
FR2847167A1 (en) * 2002-11-15 2004-05-21 Galderma Res & Dev Method for treating disorders associated with TGF-beta signal deficiency, e.g. cicatrization disorders, ulcers, cancers or graft rejection, comprises administration of retinoic acid receptor-Gamma antagonists

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648385A (en) * 1994-01-03 1997-07-15 Bristol-Myers Squibb Co. Retinoid-like compounds
FR2731706B1 (en) * 1995-03-14 1997-04-11 Cird Galderma AROMATIC HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM AND USES

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same

Also Published As

Publication number Publication date
EP1005340A1 (en) 2000-06-07
AU7105398A (en) 1998-11-11
CA2286261A1 (en) 1998-10-22
WO1998046223A1 (en) 1998-10-22
AU723146B2 (en) 2000-08-17
JP2001524082A (en) 2001-11-27

Similar Documents

Publication Publication Date Title
EP0825867A4 (en) N,o-carboxymethylchitosan for prevention of surgical adhesions
PL322549A1 (en) Inhibitors of proteinous farnesiltransferase
PL327569A1 (en) Promedications of thrombosin inhibitors
AU1711799A (en) Vasoocclusive device for treatment of aneurysms
HK1025904A1 (en) Pharmaceutical composition for combination of piperidinoalkanol-decongestant
IL118101A0 (en) Inhibitors of farnesyltransferase
PL339551A1 (en) Derivatives of rezorcin
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
SG55309A1 (en) Endovascular device for protection of aneurysm
PL338144A1 (en) Derivatives of dolastatin 15
GB9524861D0 (en) Surgical anchorage
GB9408293D0 (en) Surgical anchor
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
EP1117835A4 (en) Prevention of adhesions
EP1005340A4 (en) Retinoid antagonists for prevention of surgical adhesions
PL334769A1 (en) Derivatives of 5-aroylnaphtene
AU1011797A (en) Agents for inhibiting accumulation of visceral fat
EP0976720A4 (en) Propanolamine derivatives
GB9810127D0 (en) Prevention of surgical adhesions
GB2313315B (en) Surgical devices
IL120005A0 (en) Pharmaceutical compositions for the treatment of the eye
ZA985064B (en) Derivatives of pentaerythrits
GB2325156B (en) Equipment for the removal of cosmetics
EP1003493A4 (en) Use of selective rxr agonists to prevent surgical adhesions
GB9817348D0 (en) Pharmaceutical use of esters

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991111

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20001227

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030507

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 43/00 B

Ipc: 7A 61K 31/27 B

Ipc: 7A 61K 31/35 B

Ipc: 7A 61K 31/385 B

Ipc: 7A 61K 31/38 A

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040924